Clinical trials
Recruiting Myeloproliferative Disorders trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda Ospedaliero-Universitaria di Parma | 4 |
| University Hospital, Angers | 2 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Hannover Medical School | 1 |
| Massachusetts General Hospital | 1 |
| University Hospital, Bordeaux | 1 |
| University of Miami | 1 |
| University of Nebraska | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myeloproliferative Disorders | 12 |
| Leukemia | 3 |
| Multiple Myeloma | 3 |
| Primary Myelofibrosis | 3 |
| Lymphoma | 2 |
| Lymphoproliferative Disorders | 2 |
| Myelodysplastic Syndromes | 2 |
| Thrombocythemia, Essential | 2 |
| Carcinoma, Squamous Cell | 1 |
| Hematologic Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.